GNH USA

Europe — EMA

Mycophenolate Mofetil Accord Healthcare

GNH USA supplies Mycophenolate Mofetil Accord Healthcare (Mycophenolate Mofetil), an immunosuppressant for organ transplant rejection. Request a quote.

Mycophenolate Mofetil

Request sourcing

1
Pack/s

What is Mycophenolate Mofetil?

Mycophenolate Mofetil, the active ingredient in Mycophenolate Mofetil Accord Healthcare, is an immunosuppressant presented as an oral formulation for oral use. It is employed to prevent acute organ transplant rejection and to treat proliferative lupus nephritis in appropriate patients. It is indicated for use in adult and pediatric patients where clinically appropriate.

GNH USA supplies Mycophenolate Mofetil Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

What is Mycophenolate Mofetil used for?

Mycophenolate Mofetil is used in immunosuppressive therapy to manage transplant rejection and autoimmune kidney disease.

- Prevention of acute rejection in solid organ transplantation: reduces the risk of graft loss in kidney, heart and liver transplants. - Maintenance of graft function in organ transplant recipients: supports long‑term graft survival. - Treatment of proliferative lupus nephritis: helps control renal inflammation in systemic lupus erythematosus.

What are the side effects of Mycophenolate Mofetil?

Adverse reactions may occur with Mycophenolate Mofetil therapy.

Common Side Effects: - Nausea - Diarrhea - Abdominal pain

Serious or Rare Side Effects: - Severe infection - Leukopenia or other blood‑cell abnormalities - Hepatic dysfunction

What precautions apply to Mycophenolate Mofetil?

Before initiating therapy, clinicians should consider several safety measures.

- Monitor blood counts: perform regular complete blood count assessments. - Monitor renal function: adjust therapy based on creatinine clearance. - Monitor liver enzymes: watch for signs of hepatic injury. - Contraindicated in pregnancy: drug is classified as Category X; avoid use. - Use effective contraception: ensure reliable birth control for patients of reproductive potential. - Store at below 25°C: keep in the original pack, protect from moisture.

What does Mycophenolate Mofetil interact with?

Mycophenolate Mofetil can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Azathioprine: additive bone‑marrow suppression. - Cyclosporine: increased mycophenolic acid exposure. - Live vaccines: heightened risk of infection.

Moderate Interactions (Monitor Closely): - Antacids: may reduce oral absorption. - Rifampin: induces metabolism, lowering drug levels.

Frequently asked questions

What is Mycophenolate Mofetil used for?+
Mycophenolate Mofetil is an immunosuppressant prescribed to prevent acute rejection after solid organ transplantation, to maintain long‑term graft function, and to treat proliferative lupus nephritis in patients where immune modulation is required.
How does Mycophenolate Mofetil work?+
The drug blocks inosine monophosphate dehydrogenase (IMPDH), an enzyme essential for de novo guanosine nucleotide synthesis. By limiting guanosine availability, it suppresses the proliferation of T‑ and B‑lymphocytes, reducing immune responses that can damage transplanted organs or inflamed kidneys.
What is the usual dose of Mycophenolate Mofetil?+
Dosing is individualized. The prescribing clinician determines the appropriate amount based on the patient’s condition, body weight, renal function, and other concurrent therapies. Patients should follow the exact regimen provided by their healthcare professional.
Is Mycophenolate Mofetil safe during pregnancy or breastfeeding?+
Mycophenolate Mofetil is classified as Pregnancy Category X because it can cause fetal harm. It is contraindicated in pregnancy, and women of child‑bearing potential must use effective contraception. Safety during breastfeeding has not been established, and nursing is generally discouraged.
How do I order Mycophenolate Mofetil Accord Healthcare from GNH USA?+
Submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Mycophenolate Mofetil compare with other immunosuppressants?+
Compared with calcineurin inhibitors such as cyclosporine or tacrolimus, Mycophenolate Mofetil offers a different mechanism—targeting lymphocyte proliferation rather than cytokine production. It is often used in combination regimens to achieve synergistic immunosuppression while allowing lower doses of each agent.
What are the storage and handling requirements for Mycophenolate Mofetil?+
Store the product at temperatures below 25 °C, in its original packaging, and protect it from moisture and direct sunlight. Do not expose the medication to excessive heat or humidity, and keep it out of reach of children.
How is Mycophenolate Mofetil administered?+
Mycophenolate Mofetil is taken orally, usually as tablets or capsules, with or without food as directed by the prescriber. The exact dosing schedule—once or twice daily—depends on the therapeutic indication and patient-specific factors.
What are the most serious risks associated with Mycophenolate Mofetil?+
Serious risks include severe infections due to immunosuppression, bone‑marrow suppression leading to leukopenia or anemia, and potential liver injury. Patients should be monitored regularly for signs of infection, blood‑cell abnormalities and hepatic dysfunction.
Who should not use Mycophenolate Mofetil?+
The drug is contraindicated in pregnant women, individuals with known hypersensitivity to mycophenolate or any component of the formulation, and patients with severe uncontrolled infections. Caution is also advised for those with significant renal or hepatic impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Mycophenolate Mofetil
Route
Oral Use
Manufacturer
Accord Healthcare Limited
Origin
EU

Related products

CellCept 250 mg/1

CellCept 250 mg/1

Mycophenolate Mofetil · 250 mg

CellCept
CAPSULE
Genentech, Inc.
USA
CellCept 250 mg/1

CellCept 250 mg/1

Mycophenolate Mofetil · 250 mg

CellCept
CAPSULE
Genentech, Inc.
USA
CellCept 500 mg/1

CellCept 500 mg/1

Mycophenolate Mofetil · 500 mg

CellCept
TABLET, FILM COATED
Genentech, Inc.
USA
CellCept 500 mg/1

CellCept 500 mg/1

Mycophenolate Mofetil · 500 mg

CellCept
TABLET, FILM COATED
Genentech, Inc.
USA